SEC 13F Intelligence

M28 Capital Management LP / STOK

M28 Capital Management LP’s Stoke Therapeutics Inc Position

Does M28 Capital Management LP own Stoke Therapeutics Inc (STOK)? Not currently — the last reported position was 346.2K shares worth $4M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q2 2023
Shares
346.2K
% of Portfolio
+4.86%
Quarters Held
7
position exited

Position History STOK

Reported value by quarter
Q4 ’21: $13MQ4 ’21Q1 ’22: $11MQ1 ’22Q2 ’22: $7MQ2 ’22Q3 ’22: $7MQ3 ’22Q4 ’22: $4MQ4 ’22Q1 ’23: $4MQ1 ’23Q2 ’23: $4MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023346.2K$4M+4.86%
Q1 2023532.9K$4M+5.02%
Q4 2022482.9K$4M+4.25%
Q3 2022522.5K$7M+7.00%
Q2 2022527.1K$7M+7.81%
Q1 2022527.1K$11M+10.20%
Q4 2021527.1K$13M+9.87%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of STOK.